-
-
-
-
-
-
-
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
-
-
-
-
-
-
-
QIAGEN issues $750 million convertible bonds due 2032
-
-
-
-
-
-
-
QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook
-
-
-
-
-
-
-
Qiagen (QGEN) fully acquires NeuMoDx Molecular
-
-
-
-
-
-
-
Thermo Fisher Scientific Provides Process Overview for the Announcement of Final Offer Results
-
-
-
-
-
-
-
Thermo Fisher Scientific Publishes Offer Document for Voluntary Tender Offer for All Ordinary Shares of QIAGEN N.V.
-
-
-
-
-
-
-
Thermo Fisher Scientific to Acquire QIAGEN N.V.
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

